Crossref
Towards better outcomes: segmentectomy for ground-glass opacity-dominant non-small cell lung cancer 3 cm or less—insights from JCOG1211
AME Clinical Trials Review · 2023
DOI: 10.21037/actr-23-10 ↗Kurz gefasst
Fachartikel in der Zeitschrift AME Clinical Trials Review, 2023. Verfasst von Terumoto Koike und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Koike, T., Hasebe, T., Nakamura, M., Shimizu, Y., Goto, T., & Tsuchida, M. (2023). Towards better outcomes: segmentectomy for ground-glass opacity-dominant non-small cell lung cancer 3 cm or less—insights from JCOG1211. AME Clinical Trials Review. https://doi.org/10.21037/actr-23-10
Vancouver
Koike T, Hasebe T, Nakamura M, Shimizu Y, Goto T, Tsuchida M. Towards better outcomes: segmentectomy for ground-glass opacity-dominant non-small cell lung cancer 3 cm or less—insights from JCOG1211. AME Clinical Trials Review. 2023. doi:10.21037/actr-23-10
BibTeX
@article{Koike2023,
author = {Koike, Terumoto and Hasebe, Toshiki and Nakamura, Masaya and Shimizu, Yuki and Goto, Tatsuya and Tsuchida, Masanori},
title = {Towards better outcomes: segmentectomy for ground-glass opacity-dominant non-small cell lung cancer 3 cm or less—insights from JCOG1211},
journal = {AME Clinical Trials Review},
year = {2023},
doi = {10.21037/actr-23-10}
}
EUVIMED